Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Loxo Oncology, Inc.
Scientific Title
A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin Lymphoma (NHL)